1st Quarter - Report
TCH GROUP, LLC for AMGEN USA INC
Firm
Client
Income
$40,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare Coverage Reimbursement Issues Implementation of the Medicaid Drug Rebate Program HR 3590, Patient Protection and Affordable Care Act (End Stage Renal Disease) HR 4872 Health Care and Education Reconciliation Act (End Stage Renal Disease, Medicaid Drug Rebate Program)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN HOLSCLAW | — |
Health Issues HCR
S. 1695, Biologics Price Competition and Innovation Act of 2007 (Biosimilars) HR 3590, Patient Protection and Affordable Care Act (Biosimilars)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN HOLSCLAW | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.